Abstract (J Korean Assoc Oral Maxillofac Surg 2012;38:264-70) Many oral and maxillofacial bone defects are not self-healing. Guided bone regeneration (GBR), which uses a barrier membrane to prevent the soft tissues from invading the defect to enable slower-growing bone cells to penetrate the area, was developed as a therapy in the 1980s. Although there has been some success with GBR in some clinical situations, better treatments are needed. This review discusses the concept of GBR focusing on bioactive membranes that incorporate osteoconductive materials, growth factors and cells for improved oral and maxillofacial bone regeneration.
, there are some unique challenging aspects of tissue regeneration in oral and maxillofacial tissues. The irregular architecture and necessary precision of positioning the biomaterial replacements suggest injectable or moldable substitutes. Implants need sufficient mechanical properties and appropriate resorption rates that coordinate with tissue ingrowth. Moreover, the environment of the oral cavity with its flora presents additional complications for alveolar bone engineering.
Despite these challenges, guided bone regeneration (GBR) was developed and has served as a treatment since the 1980s for restoring osseous maxillofacial tissues 8, 9 . An excellent overview on this subject was provided by Buser 10 . Through the use of a barrier membrane, this therapeutic strategy physically excludes ineffective soft tissue cells to allow osteoprogenitor cells to populate the area. Since its initial conception, the GBR membranes have progressed from nonresorbable to resorbable to bioactive occlusive materials. GBR has been shown to reliably close critical size periodontal defects and can even support neo-osteogenesis, bone growth extending past the original boundaries 11 . Although there has been success with GBR in various clinical situations, others, particularly alveolar ridge augmentation combined with implant placement, require further research to improve outcomes 11 . Thus, research on advanced materials, growth factor incorporation, and the inclusion of cells is ongoing to improve GBR for oral and maxillofacial bone regeneration.
I. Introduction
Facial trauma, bone resection due to cancer, periodontal disease, and bone atrophy after tooth extraction may leave non-self-healing oral and maxillofacial bone defects 1 .
Although there is an inherent self-repair potential, a nonunion remains for bone gaps greater than 25 mm or even only 500 μ m, depending on the location, vascularization, and the mechanics 2 . The presence of infection or inflammation is another determining factor for bone regeneration capability at a given site. For the alveolar bone in particular, periodontitis, advanced periodontal disease that affects around 15% of adult humans, induces the destruction of the alveolar bone around teeth and can cause them to fall out 3, 4 . Without the mechanical stimulus from teeth, alveolar bone naturally further degrades 4, 5 . Interventions with tooth implants are additionally complicated since sufficient quantity and quality of the alveolar bone must be present to stabilize the implant 6 . Peri-implantitis, infection and inflammation around tooth implants, can have the same detrimental effects on the can decrease bone regeneration 20, 21 . Besides avoiding the second surgery, resorbable membranes are also advantageous because of improved soft tissue healing and lower bacterial contamination risk due to decreased exposure from the degrading membrane 19 . In addition to the requirements stated previously, there are also further properties that these barrier membranes must fulfill: biocompatible degradation products that don't interfere with bone regeneration, appropriate degradation profile to synchronize with new tissue growth, and sufficient persistent mechanical and physical properties to perform the barrier function and allow in vivo use 3 . Amongst the most common bioresorbable membranes are synthetic polyesters (poly(lactic acid), poly(glycolic acid), and poly(caprolactone) and their copolymers) [22] [23] [24] [25] and tissue-derived collagen 21, [26] [27] [28] [29] . Polyester membranes display biocompatibility and possess a high degree of customization, with degradation rates and mechanical properties that can be adjusted based on polymer composition and concentration 30, 31 . As a natural component of the extracellular matrix, collagen is biocompatible and cell adhesive. Although collagen isn' t inherently mechanically stable, it can be modified through various means of crosslinking 3 . Poly(ethylene glycol) (PEG) is also known as a biodegradable and biocompatible polymer. Since many oral and maxillofacial defects require precise shapes, an injectable material is desirable, such as a PEG-based in situ forming gel for GBR that demonstrated effectiveness in a clinical trial [32] [33] [34] . In addition to the type of material, the physical form also plays a role in determining a material's properties, which can affect degradation rates and tissue integration. Porosity is one of the most important characteristics. With some materials, such as poly(lactide-co-glycolide), the porosity can be imposed by using porogens that form the pores and then are removed in a subsequent processing step 35 . Electrospinning is a manufacturing technique that creates elongated fibers with a degree of control over properties including fiber length, width, and orientation and overall porosity 3 . Researchers have explored these techniques for improving GBR membranes.
Although the existing bioresorbable membranes fulfill many requirements, most of them cannot maintain adequate space to act as a barrier membrane over an extended period of time 5, 19 . However, in combination with a bone substitute material, these composite membranes have shown success 24 .
III. Bioactive Membranes
In addition to providing mechanical support to resorbable II. Guided Bone Regeneration
Concept and requirements
GBR gained traction as a therapy in the 1980s, but in 1957 there was already an initial report of space creation with plastic cages for bone regeneration in femoral defects in dogs 12 . Other studies followed, including those focusing on the craniofacial area 13, 14 , but the mechanism of action was initially hypothesized to be the protection of the blood clot. In the early 1980s, the guided tissue regeneration principle was established, explaining that a specific tissue can be rege ne rated when cells with the restorative ability for that tissue type are able to occupy the wound space 9, 15 . Through space maintenance and the preclusion of faster growing cells from the gingival connective tissue and oral mucosal epithelium, osteogenic cells are allowed to infiltrate and form bone 8, 9, [15] [16] [17] . By enabling new bone formation, GBR may obviate the use of autologous bone grafts. Although an excellent source, the use of autogenous tissue is not desirable due to the pain and morbidity associated with the graft harboring site 4, 18 .
To function properly, GBR membranes must meet certain requirements, including cell exclusion, space creation, scaffolding for progenitor cell in-growth, biocompatibility, host tissue integration, and clinical manageability 1, 11, 17 .
Non-resorbable and resorbable membranes
The first generation of barrier membranes was nonresorbable, with expanded polytetrafluorothylene (ePTFE) (Teflon; Gore, Flagstaff, AZ, USA) membranes becoming the most frequently used 1, 8, 11 . With its high stability, nonimmunogenicity, and reliably successful results, ePTFE membranes have been considered a gold standard for bone regeneration 11, 19 , despite the fact that ePTFE-membrane exposure to the oral cavity always resulted in a failure of the treatment. Even with the favorable outcomes using non-resorbable ePTFE, the strong disadvantage of requiring a second surgery to remove the material encouraged the development of a second generation of GBR with degradable barrier membranes. Along with the morbidity associated with a second surgical procedure for non-resorbable membrane removal, there is a risk of tissue damage and disturbed healing 19 . Additionally, there are some post-surgical complications of membrane exposure with non-biodegradable membranes that lead to a high incidence of infection that glass is another inorganic bone graft material that displays osteoconduction and an ability to bond with bone through chemical linkages 46, 47 . 3, 48, 49 . Platelet rich plasma is comprised of various autologous growth factors that have individually been identified to enhance bone regeneration, including platelet-derived growth factor 50 , fibroblast growth factor 51 , and insulin-like growth factor 52 , but its positive effect on regeneration processes appears to be restricted to soft tissue healing 49, 53 . The class of bone morphogenetic proteins (BMPs), first identified to generate extraskeletal bone formation in bone extracts in 1965 54 , have now been extensively studied and shown to be critical for the induction of bone 55 . The class of BMPs consists of 15 variants, with BMP-2, BMP-4, BMP-7, and BMP-12 shown to be particularly effective in bone regeneration 56 . BMP-2 and BMP-7 have been recombinantly produced for commercial use 45 . BMP-2 has shown impressive potential to regenerate bone in animal studies and the clinic, including in oral applications 57 . GBR in conjunction with BMP-2 delivery by a bone substitute material has been shown to be an effective strategy in humans as well 58 . However, milligram doses that are orders of magnitude higher than normal physiological levels are required 59 . An enhancer of BMP-2, such as N-methyl pyrrolidone (NMP), can possibly avoid the high cost and possible side effects and safety concerns of the large dose 60 . In a rabbit calvarial model, NMP enhanced bone regeneration over a polylactide membrane alone, emphasizing the importance of the bioactivity 61 . Besides enhancers, controlled release of growth factors can increase their efficiency. In fact, acting as a vehicle for local delivery of growth factors and protecting them from degradation and inactivation are major roles of biomaterials.
Growth factors
GBR membranes, the inclusion of bone substitute materials can render a membrane bioactive. Current research aims to develop a third generation of GBR membranes that are not only occlusive and degradable, but also contain bioactivity to biologically stimulate osteoprogenitor cells for enhanced bone growth. Using tissue engineering principles, advanced materials with the incorporation of bioactive molecules and cells are being explored for the development of the next generation of membranes. Instead of simply maintaining a space for osteoprogenitor ingrowth, the critical aspects of the natural environment are being recapitulated.
Bone graft materials
Effective bone graft materials can biologically stimulate bone growth through either osteoconduction by allowing cell growth through a scaffolding mechanism or osteoinduction by recruiting osteoprogenitors into the defect space 4 .
Although cancellous autogenous bone grafts act as an osteoconductive material, the associated morbidity of the graft site restricts its use. Other natural sources include both allografts and xenografts, which are processed to reduce immunogenicity 36 . Demineralized bovine bone matrix retains type-1 collagen, non-collagenous proteins as well as a small amount of osteoinductive growth factors 37 . One of the most common commercially used products is deproteinized bovine bone matrix, Bio-Oss (Geistlich Biomaterials, Wolhusen, Switzerland), which is stripped of all organic elements by pyrolysis, a high temperature sintering, leaving hydroxyapatite (HA) as the main component 38 . Unfortunately, high temperature sintering also affects HA and alters it from a biological HA to a more synthetic one 39 .
Despite positive outcomes of naturally-derived materials, there are still concerns regarding disease transmission and immunogenicity 4 . Synthetic graft materials supply various formulations of calcium phosphate without the limitations of the animalderived products. Bone is composed of a majority of calcium phosphate and these synthetic substitutes are known to have biologically active surface chemistry for osseointegration 40 . Additionally, these biodegradable, inorganic materials have a crystallographic structure similar to bone and controllable porosity that is important for mimicking bone, making them effective substitutes 41, 42 . HA has been utilized as granules 42, 43 , incorporated as nanoparticles 3 , or as a coating 44 . Tricalcium phosphate (TCP), which resorbs faster than HA, is another commonly used inorganic bone substitute 41, 45 . In addition to BMSCs, there are several other cell types that are being explored for oral and maxillofacial bone tissue engineering. Umbilical cord MSCs are another easily obtainable reservoir of stem cells and initial studies show promising results for bone regeneration with this source [83] [84] [85] [86] . Adipose-derived stem cells are other extraoral and non-craniofacial cells that are easily accessible and were successfully used to regenerate bone 87, 88 . The periodontal ligament and dental pulp are both sources of stem cells in the oral cavity that have been isolated and characterized 56, 89 . Stem cells from both of these tissues have demonstrated bone regeneration capabilities [90] [91] [92] . However, these cells are more difficult to harvest 36 . With all of these stem cells sources, the biomaterial that supports them is a critical aspect for facilitating bone regeneration. Many of the same materials that have been developed as bone graft materials and bioactive molecule delivery vehicles have been explored as cell scaffolds. HA 93 , collagen 94 , fibrin 87 , and poly(lactide-co-glycolide) 95 as well as composites such as HA/TCP
96
, chitosan-gelatin 79 , and calcium phosphate cement-chitosan-polyglactin 86 are amongst these scaffolds.
IV. Conclusion
The field of bone regeneration for oral and maxillofacial tissues has progressed dramatically from the first nonresorbable GBR membranes to bioactive materials. Guided by tissue engineering principles, there is a large amount of current research on designing membranes consisting of bioactive materials that can deliver growth factors and cells. Future improvements will require appropriate combinations of materials, growth factors and cells that permit temporal and spatial growth factor release, suitable degradation profiles that both allow tissue ingrowth and maintain sufficient occlusivity, and positive mimicking of the extracellular matrix to support and encourage cell proliferation and differentiation. Composite materials, multilayered constructs, and varying physical forms are amongst the possible strategies in biomaterial development for this A slow, controlled release BMP-2 delivery system has been shown to induce and sustain bone formation 62 . Many of the same materials used as bone grafts have also been explored as delivery systems: collagen 63 ). The materials that physically incorporate growth factors can take various forms from liposomes 69 to nanoparticles 70 to hydrogels 71 . In contrast to these modes of delivery, covalent systems retain growth factors at the site of action until cleaved off or the carrier is degraded, extending the residence time 66 . Additionally, immobilization enables spatial growth factor delivery, limits side effects by constraining the growth factors to the site of action, and mimics physiological matrix-bound situations 72 . Growth factors can be covalently tethered to a material directly 73, 74 or through a linker 75, 76 . Another strategy is genetically engineering fusion growth factors that include an attachment site outside the active protein sequence. BMP-2 was engineered to contain amino acid domains that enable both enzymatic covalent attachment to and release from fibrin-based substances, creating a system that mimics physiological binding and liberation 77 . Although it is possible that the growth factor may lose some activity through all of these covalent immobilization methods, this loss may be mitigated by the higher retention and other advantages.
Cells
In addition to allowing the delivery of bioactive molecules, biomaterials are also critical for enabling cell-based therapies. To encourage proliferation and differentiation, cells require an artificial extracellular matrix, which can be supplied through an appropriately designed biomaterial 36 . Including a cell source can further encourage oral and maxillofacial bone growth through direct tissue growth and bone repair as well as growth factor secretion from the cells 78 . Although this area has only been actively pursued relatively recently, due to advancements in biological cell research, there are some promising studies.
Mesenchymal stem cells (MSCs), multipotent adult stem cells that can be harvested from mesenchymal tissues such as
